<DOC>
	<DOCNO>NCT00151294</DOCNO>
	<brief_summary>Emotionally labile , depressed participant multiple sclerosis treat escitalopram great reduction emotional lability score psychological distress score randomize receive placebo .</brief_summary>
	<brief_title>The Efficacy Safety Escitalopram Depression Multiple Sclerosis</brief_title>
	<detailed_description>Patients multiple sclerosis experience mood lability symptom depression randomize receive either escitalopram 10mg/day placebo tablet period 6 week . It hypothesize patient receive medication experience great normalization emotional instability great reduction depressive symptom end six-week trial receive medication .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Clinical diagnosis multiple sclerosis Having mild moderate depressive symptom , without emotional lability Experiencing psychological distress Meeting DSMIV diagnostic criterion Major Depressive Disorder another Axis 1 diagnosis Cognitive impairment The presence unstable medical illness might preclude completion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Depression ( mild moderate )</keyword>
	<keyword>Affective symptom</keyword>
	<keyword>Emotional lability</keyword>
	<keyword>Multiple Sclerosis</keyword>
</DOC>